Can a new injection shrink nasal polyps and restore easy breathing?
Disease control
Completed
This phase II trial is testing an experimental biologic called CM512 in about 120 people with chronic rhinosinusitis and nasal polyps—non-cancerous growths that block the nose and cause congestion. Participants receive either CM512 or a placebo as a subcutaneous injection, and re…
Phase 2 • Sponsor: Beijing Keymed Biosciences Co., Ltd. • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC